Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The new screenshot shows only minor UI/layout adjustments with no updates to core trial data (title, conditions, interventions, eligibility criteria, primary outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:09:39.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T09:57:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:04.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:59:05.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T14:28:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, as well as specific details about a clinical trial involving cabozantinib for renal cell carcinoma. Additionally, the revision number has been updated to v3.0.0.
    Difference
    7%
    Check dated 2025-08-30T11:17:24.000Z thumbnail image

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.